Remove 2025 Remove Marketing Remove Pharmacy
article thumbnail

The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Click here to see the original post from April 2025. DCI has identified nearly 1,900 dispensing locations with specialty pharmacy accreditation. All rights reserved.

article thumbnail

Smaller Pharmacies, Bigger Impact: Inside Manufacturers’ Specialty Networks in 2025

Drug Channels

Last week, we examined the growing concentration of specialty drug dispensing revenues among the largest pharmacies. See The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market. Drawing from DCIs new 2025 Economic Report on U.S. Today, we dive deeper. All rights reserved.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments

Drug Channels

Threes still company in the world of pharmacy benefit managers. Below, we break down the latest market share data from Drug Channels Institute (DCI), explore the developments driving these changes, and examine what they signal for the future of the PBM landscape. P.S. Special launch pricing on our new 2025 Economic Report on U.S.

article thumbnail

The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Click here to see the original post from March 2025. Three’s still company in the world of pharmacy benefit managers. All rights reserved.

article thumbnail

The 340B Contract Pharmacy Market in 2025: Big Chains and PBMs Tighten Their Grip

Drug Channels

The 340B Drug Pricing Program has emerged as a growing source of profits for pharmacies and pharmacy benefit managers (PBMs). pharmacy industry—function as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. It was meant to be part of patient care.” Fein, Ph.D.,

article thumbnail

The Top 15 U.S. Pharmacies of 2024: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Click here to see the original post from March 2025. Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U.S. All rights reserved.

article thumbnail

Why 340B Reform Could Happen in 2025 (video)

Drug Channels

During my recent Drug Channels Outlook 2025 video webinar, I tackled a wide range of crucial topicsincluding the controversial 340B Drug Pricing Program. As I explain in this video excerpt, we may finally see reform of this rapidly expanding program.